Discovery Programs
R&D Pipeline
Gubra has a strong R&D pipeline for target discovery and peptide drug discovery. Our focus is on metabolic, fibrotic, and inflammatory diseases, where we are scientific experts.
Why Gubra?
-
Innovative and data-driven approach
-
Expert guidance in target and diseases
-
High quality data, integrity, speed and flexibility
-
Professional and agile project organization
Consult with Lise Biehl Rudkær
Director, Business Development
Choose the right, trustworthy discovery partner.
Healthy mix of internal & partnered programs
Gubra’s R&D Pipeline
Gubra´s R&D pipeline is a healthy mix of partnered programs and internal programs aimed for partnering now or at a later stage. Please get in contact if you would like to hear more.
“
Our scientific expertise and AI-driven platforms are key to our strong pipeline.
We combine our AI and machine-learning platforms with cutting-edge science to quickly move forward our programs. Our agile approach and complete in-house capabilities ensures speed and high data quality.
Niels Vrang, CSO (co-founder)
Key figures
5
Active Partnerships
- Current collaboration partners: Boehringer Ingelheim, Bayer, and Silence Therapeutics
- A longterm trusted alliance partner
3
Clinical Development
- Three projects in clinical development phase
- One project in Phase I
9+
Open Projects
- A diverse portfolio of internal projects
- Ready to be partnered now or later
Related pages
For further information
Contact us
Gubra
Hørsholm Kongevej 11B
2970 Hørsholm
Denmark
+45 3152 2650